
BioSyent Finalizes $25.5 Million Acquisition of Oral Science Inc., Expanding Dental Product Portfolio
BioSyent Inc., a public company listed on the TSX Venture Exchange, has announced its plan to acquire Oral Science Inc., a Canadian distributor of dental









